Survival outcomes with matched targeted therapy in advanced biliary tract cancer: a large global cohort analysis
Binbin Zheng-Lin(WinnMed), Tanios Bekaii-Saab(Mayo Clinic in Arizona), Oluseyi Abidoye(Mayo Clinic), Taro Shibuki(National Cancer Center Hospital East), Mitesh J. Borad(Jacksonville College), Tadayoshi Hashimoto(Osaka University), Heidi Kosiorek(Mayo Clinic in Florida), Lewis R. Roberts(Mayo Clinic), Ryne C. Ramaker(Duke Medical Center), Mitsuho Imai(National Cancer Center Hospital East), Celine Hoyek(Mayo Clinic Hospital), Madhuri Gottam, Hani Babiker(Mayo Clinic in Florida), Daniel H. Ahn(WinnMed), John H. Strickler(Duke University), Christina Wu(WinnMed), Shinji Itoh(Kyushu University), Masafumi Ikeda(National Cancer Center Hospital East), Nguyen H. Tran(Mayo Clinic in Arizona), Cody R. Eslinger(WinnMed), Hideaki Bando(National Cancer Center Hospital East), Makoto Ueno(Kanagawa Prefectural Hospital Organization), Yasuyuki Kawamoto(Hokkaido University Hospital), Takao Fujisawa(National Cancer Center Hospital East), Yoshiaki Nakamura(National Cancer Center Hospital East), Mohamad B. Sonbol(WinnMed), Takayuki Yoshino(National Cancer Center Hospital East), Angelo Pirozzi(Humanitas University), Chigusa Morizane, Ashley Moyer(Duke University)
Cited by 0
Related Papers
Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer
|Cell|2018|2.8k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k
The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma
|Cell Reports|2018|818